Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

TBC (erenumab )

Indications: Migraine

Call For Patient Input: July 12, 2018

Patient Input Closed: August 31, 2018

Jublia (efinaconazole)

Indications: Onychomycosis

Call For Patient Input: July 4, 2018

Patient Input Closed: August 23, 2018

Spinraza (Nusinersen)

Indications: Spinal Muscular Atrophy

Call For Patient Input: June 22, 2018

Patient Input Closed: August 14, 2018

Xeljanz (tofacitinib )

Indications: Arthritis, Psoriatic

Call For Patient Input: June 12, 2018

Patient Input Closed: August 1, 2018

Brineura (cerliponase alfa )

Indications: Neuronal Ceroid Lipofuscinosis Type 2

Call For Patient Input: June 4, 2018

Patient Input Closed: July 24, 2018